Evgen Pharma

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.


Acceleris Capital Ltd. Lowry House, 17 Marble Street, Manchester, M2 3AW.

Tel: 0161 850 0156

Fax: 0161 637 0462

General Enquiry Investment Enquiry Upload Business Plan